Abstract:Background β-Nicotinamide mononucleotide (NMN) is the direct precursor of nicotinamide coenzymes such as NAD + and NADP + , which are widely applied in industrial biocatalysis especially involving cofactor-dependent oxidoreductases. Moreover, NMN is a promising candidate for medical uses since it is considered to be beneficial for improving health of aged people who usually suffer from an insufficient level of NAD + . To date, various methods have been developed for the synthesis of NMN. Chemical phosphorylation of nicotinamide riboside (NR) to NMN depends on excessive phosphine oxychloride and delicate temperature control, while fermentation of NMN is limited by low product titers, making it unsuitable for industrial-scale NMN production. As a result, the more efficient synthesis process of NMN is still challenging. Aim This work attempted to construct an eco-friendly and cost-effective biocatalytic process for transforming the chemically synthesized NR into the highly value-added NMN. Results A new nicotinamide riboside kinase ( Klm- NRK) was identified from Kluyveromyces marxianus . The specific activity of purified Klm- NRK was 7.9 U·mg –1 protein, ranking the highest record among the reported NRKs. The optimal pH of Klm -NRK was 7.0 in potassium phosphate buffer. The purified Klm -NRK retained a half activity after 7.29 h at 50 °C. The catalytic efficiencies ( k cat / K M ) toward ATP and nicotinamide riboside (NR) were 57.4 s −1 ·mM −1 and 84.4 s −1 ·mM −1 , respectively. In the presence of an external ATP regeneration system (AcK/AcP), as much as 100 g·L –1 of NR could be completely phosphorylated to NMN in 8 h with Klm -NRK, achieving a molar isolation yield of 84.2% and a space–time yield of 281 g·L −1 ·day −1 . These inspiring results indicated that Klm -NRK is a promising biocatalyst which provides an efficient approach for the bio-manufacturing of NMN in a high titer. Graphical Abstract

Structure-guided mining and engineering of nicotinamide riboside kinase for efficient synthesis of nicotinamide mononucleotide

Design and tailoring of an artificial DNA scaffolding system for efficient production of nicotinamide mononucleotide

Enzymatic Synthesis of High-Titer Nicotinamide Mononucleotide with a New Nicotinamide Riboside Kinase and an Efficient ATP Regeneration System

Improvement of an enzymatic cascade synthesis of nicotinamide mononucleotide via protein engineering and reaction-process reinforcement

High Level Expression of Nicotinamide Nucleoside Kinase from Saccharomyces Cerevisiae and Its Purification and Immobilization by One-Step Method

Technology and functional insights into the nicotinamide mononucleotide for human health

Systematic Engineering of Escherichia coli for Efficient Production of Nicotinamide Mononucleotide From Nicotinamide

Synthesis of NMN by cascade catalysis of intracellular multiple enzymes

Metabolic Engineering of Bacillus licheniformis for the Bioproduction of Nicotinamide Riboside from Nicotinamide and Glucose

Biosynthesis of Nicotinamide Mononucleotide: Current Metabolic Engineering Strategies, Challenges, and Prospects

High-Level Production of Nicotinamide Mononucleotide by Engineered Escherichia Coli.

NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells

Biological production of nicotinamide mononucleotide: a review

Metabolic engineering of Escherichia coli for optimized biosynthesis of nicotinamide mononucleotide, a noncanonical redox cofactor

Advances in the Synthesis and Physiological Metabolic Regulation of Nicotinamide Mononucleotide

De novo biosynthesis and nicotinamide biotransformation of nicotinamide mononucleotide by engineered yeast cells

Secretion and Expression of Enzymes in the Nicotinamide Mononucleotide Synthesis Pathway and the Optimization of the Catalytic System in Escherichia coli

An Overview of Engineering Microbial Production of Nicotinamide Mononucleotide.

Harnessing lactic acid bacteria for nicotinamide mononucleotide biosynthesis: a review of strategies and future directions

Exploring the De Novo NMN Biosynthesis as an Alternative Pathway to Enhance NMN Production

Enhancing nicotinamide mononucleotide production from glucose in Escherichia coli by genetic engineering